78533
Water
for TOC analysis
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
H2O
CAS Number:
Molecular Weight:
18.02
UNSPSC Code:
12191602
NACRES:
NA.21
PubChem Substance ID:
EC Number:
231-791-2
Beilstein/REAXYS Number:
2050024
MDL number:
Bp:
100 °C (lit.)
Vapor pressure:
3 mmHg
vapor density
<1 (vs air)
Quality Level
vapor pressure
3 mmHg
shelf life
limited shelf life, expiry date on the label
dilution
(for analytical testing)
impurities
≤0.10 mg/L TOC
refractive index
n20/D 1.34 (lit.)
bp
100 °C (lit.)
mp
0 °C (lit.)
density
1.000 g/mL at 3.98 °C (lit.)
suitability
suitable for (TOC analysis)
application(s)
environmental
food and beverages
general analytical
SMILES string
O
InChI
1S/H2O/h1H2
InChI key
XLYOFNOQVPJJNP-UHFFFAOYSA-N
General description
Total organic carbon analysis is a methodology to measure the carbon content of dissolved and particulate organic matter present in water. TOC analysis helps removal of inorganic carbon, oxidation of organic carbon into CO2 and quantifying CO2.
Still not finding the right product?
Explore all of our products under Water
Storage Class
12 - Non Combustible Liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Frank R. Spellman
Handbook of Water and Wastewater Treatment Plant Operations, 50-50 (2008)
Mary A Rodgers et al.
The Journal of experimental medicine, 211(7), 1333-1347 (2014-06-25)
Linear ubiquitination is a newly discovered posttranslational modification that is currently restricted to a small number of known protein substrates. The linear ubiquitination assembly complex (LUBAC), consisting of HOIL-1L, HOIP, and Sharpin, has been reported to activate NF-κB-mediated transcription in
Yasushi Itoh et al.
PLoS pathogens, 10(6), e1004192-e1004192 (2014-06-20)
Highly pathogenic avian influenza (HPAI) viruses of the H5N1 subtype often cause severe pneumonia and multiple organ failure in humans, with reported case fatality rates of more than 60%. To develop a clinical antibody therapy, we generated a human-mouse chimeric